Dr. Shishir Seth is a highly experienced Consultant in Hemato-Oncology and Bone Marrow Transplant at the Apollo Cancer Institute, Indraprastha Apollo Hospitals, New Delhi. With over 15 years of clinical practice since 2009, he brings deep expertise in the management of blood disorders, hematologic malignancies, and bone marrow transplantation. His comprehensive training spans across India and Canada, making him a trusted specialist for patients seeking advanced hematology and transplant care. Dr. Seth holds an MD and a DM in Clinical Hematology (Mumbai), and has further honed his skills through a prestigious Fellowship in Leukemia and Blood and Marrow Transplant (BMT) at the Division of Hematology, Vancouver General Hospital, Vancouver, Canada. His areas of specialization include blood and marrow transplant, management of acute and chronic leukemias, lymphomas, myelodysplastic syndromes, and other complex blood disorders. He is dedicated to delivering evidence-based, compassionate care to both adult and pediatric patients from around the world. Dr. Seth is also actively involved in clinical research and has contributed to multiple publications and investigator-initiated studies, reflecting his commitment to advancing the field of hematology and transplant medicine.
- Hematology & BMT
- Bone Marrow Transplant
- Allogeneic Bone Marrow Transplant
- Autologous Bone Marrow Transplant
- Matched Sibling Donor Transplant
- Matched Unrelated Donor Transplant
- Haploidentical Bone Marrow Transplant
- Myelodysplastic Syndromes Treatment
- Bone Marrow Failure Syndromes
- Chemotherapy for Solid Tumors
- Immunotherapy for Advanced Cancer
- Targeted Therapy for Solid Tumor Cancers
- DM
– Clinical Hematology, Mumbai
- MD – Medicine
- Fellowship – Leukemia and Blood and Marrow Transplant (BMT), Division of Hematology, Vancouver General Hospital, Vancouver, Canada
- Indraprastha Apollo Hospital, New Delhi
- Life Member, Indian Society of Hematology and Transfusion Medicine
- Member, American Society of Clinical Oncology
- Member, American Society of Hematology
- Principal Investigator for 2010DRL001: An investigator-initiated observational study to evaluate the response rate and toxicity (safety) of the combination of Bendamustine and Rituximab (BR) in fresh adult chronic lymphocytic leukemia patients.
- Principal Investigatorfor IVPL_RT_01: A study of Rituximab in patients with Non-Hodgkins Lymphoma.
- Published article: "An unusual presentation of pediatric acute lymphoblastic leukemia." Indian J Hematol Blood Transfus. 2008; 24(2) 59-62. - Published article: "Hematopoietic cell transplantation in lymphoma: Why & when – Evidence-based review." *Cancer News.* Dec 2011; 5(5) 10-12.
- Awarded at the annual conference of the ICS (Indian Cytometry Society) and Asia Nano Hematology Conference (ANHC) for best oral and poster presentations.
- Recognized at a national conference for a study on graft-versus-host disease and multiple myeloma-related research.
From your first enquiry to recovery back home — we manage every detail so you can focus on getting better.
Join 5,000+ patients from 40+ countries who chose world-class care at a fraction of the cost.
